Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-306110

Chief Operating Officer sold 4,351 shares at $23.38 ($101,730)

  • Chief Operating Officer acquired 4,351 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Champoux Jennifer · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-15 Exercise or conversion : show line 1 in the form 10b5-1 +4,351 $3.98 $17,317 66,722 D
2026-07-15 Sale : show line 2 in the form 10b5-1 −4,351 $23.38 $101,730 62,371 D
Open-market sales · 4,351 sh · avg $23.38 · $101,730

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-15 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −4,351 26,947 D
Loading xslF345X06/ownership.xml…